Effects of DFMO on glioma cell proliferation, migration and invasion in vitro

Journal of Neuro-Oncology

Volumn 36, Issue 2, 1998, Pages 113-121

  Terzis, A Jorge A ^a,d   Pedersen, Paal Henning ^b   Feuerstein, Burt G ^c   Arnold, Hans ^a   Bjerkvig, Rolf ^b   Deen, Dennis F ^c  

^a Department of Neurosurgery ^*  (Germany)

^b Inst of Anatomy and Cell Biology   (Norway)

^c Brain Tumor Research Center   (United States)

^d UNIVERSITY OF LÜBECK   (Germany)

Author keywords

DFMO; Glioma; Invasiveness; Polyamines; Three dimensional culture

Indexed keywords

EFLORNITHINE; ENZYME INHIBITOR; ORNITHINE DECARBOXYLASE; PUTRESCINE;

ANIMAL CELL; ARTICLE; CANCER INVASION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; FETUS; GLIOMA CELL; HUMAN; HUMAN CELL; MULTICELLULAR SPHEROID; NONHUMAN; POLYAMINE SYNTHESIS; RAT; SPHEROID CELL;

ADULT; ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL MOVEMENT; EFLORNITHINE; FEMALE; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; RATS; RATS, WISTAR; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 0031930180     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005811403041     Document Type: Article

References (37)

1. Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS, Tsakuda Y: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52: 997-1007, 1983
2. EORTC Brain Tumor Group: Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. J Neurosurg 55: 27-31, 1981
3. Walker MD: Brain tumor study group: a survey of current activities. Natl Cancer Inst Monogr 46: 209-212, 1977
4. Levin VA, Chamberlain MC, Prados MD, Choucair AK, Berger MS, Silver P, Seager M, Gutin PH, Davis RL, Wilson CB: Phase I/II study of the combination of DEMO and MGBG for the treatment of primary brain tumors. Cancer Treat Rep 71: 459-464, 1987
5. Prados MD, Rodriguez L, Chamberlain MC, Silver P, Levin VA: Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl)-1-nitrosourea and α-difluoromethylornithine. Neurosurgery 24(6): 806-809, 1989
6. Jänne J, Pösö H, Raina A: Polyamines in rapid growth and cancer. Biochim Biophys Acta 473: 241-293, 1978
7. Takami H, Romsdahl MM, Nishioka K: Polyamines in blood cells as a cancer markers. Letter Lancet 2: 912-914, 1979
8. Caldarera CM, Barbiroli B, Moruzzi G: Polyamines and nucleic acids during development of the chick embryo. Biochem J 97: 84-88, 1965
9. Pegg AE, McCann PP: Polyamine metabolism and function. Am J Physiol 243: C212-C221, 1982
10. Luk GD, Casero RA: Polyamines in normal and cancer cells. Adv Enzyme Regul 26: 91-105, 1987
11. 5dC)-poly (dG-me5dC). Proc Natl Acad Sci USA 78: 1619-1623, 1981
12. Basu HS, Feuerstein BG, Deen DF, Lubich WP, Bergeron RJ, Samejima K, Marton LJ: Correlation between the effects of polyamine analogs on DNA conformation and cell growth. Cancer Res 49: 5591-5597, 1989
13. Tabor CW, Tabor H: Polyamines. Annu Rev Biochem 53: 749-790, 1984
14. Pegg AE, Williams-Ashman HG: Biosynthesis of putrescin. In: Morris DR, Marton LJ (eds) Polyamines in Biology and Medicine. Marcel Dekker, Inc., New York, 1979, pp 3-42
15. Metcalf BW, Bey P, Danzin C, Jung MJ, Casara P, Vevert JP: Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and products analogues. J Am Chem Soc 100: 2551-2553, 1978
16. Mamont PS, Duschene M-C, Grove J, Bey P: Antiproliferative properties of D,L-α-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase. Biochem Biophys Res Commun 81: 58-66, 1978
17. Sunkara PS, Prakash NJ, Mayer GD, Sjoerdsma A: Tumor suppression with a combination of α-difluoromethyl-ornithine and interferon. Science 219: 851-853, 1983
18. Sunkara PS, Baylin SB, Luk GD: Inhibitors of polyamine biosynthesis: cellular and in vivo effects on tumor proliferation. In: McCann PP, Pegg AE, Sjoerdsma A (eds) Inhibition of Polyamine Metabolism, FL: Academic Press, Orlando, 1987, pp 121-140
19. Carlsson J, Nilsson K, Westermark B, Ponten J, Sundström C, Carlsson E, Bergh J, Pahlman S, Busch C, Collins VP: Formation and growth of multicellular spheroids of human origin. Int J Cancer 31: 523-533, 1983
20. Mueller-Klieser W: Multicellular spheroids. A review on cellular aggregates in cancer research. J Cancer Res Clin Oncol 113: 101-122, 1987
21. Sutherland RM: Cell and environment interactions in tumor microregions: The multicellular spheroid model. Science 240: 177-184, 1988
22. Sutherland RM, Freyer J, Mueller-Klieser W: Cellular growth and metabolic adaptations to nutrient stress environments in tumor microregions. Int J Rad Oncol Biol Phys 12: 611-615, 1986
23. Akslen LA, Andersen KJ, Bjerkvig R: Characteristics of human and rat glioma cell grown in a defined medium. Anticancer Res 8: 797-804, 1988
24. Yuhas JM, Li AP, Martinez AO, Ladman AJ: A simplified method for production and growth of multicellular spheroids. Cancer Res 37: 3639-3643, 1977
25. Bjerkvig R: Reaggregation of fetal rat brain cells in a stationary culture system. II: Ultrastructure characterisation. In vitro Cell Dev Biol 22: 193-200, 1986
26. Bjerkvig R, Steinvaag SK, Laerum OD: Reaggregation of fetal rat brain cells in a stationary culture system. I: Methodology and cell identification. In vitro Cell Dev Biol 22: 180-192, 1986
27. Honegger P, Lenoir P, Farvrod P: Growth and differentiation of aggregating fetal brain cells in serum free defined medium. Nature 282: 305-307, 1979
28. Trapp BD, Honegger P, Richelson E: Morphological differentiation of mechanically dissociated fetal rat brain in aggregating cell cultures. Brain Res 160: 235-252, 1982
29. Trapp BD, Webster HD, Johnson D, Quarles RH, Cohen SR, Murray MR: Myelin formation in rotation-mediated aggregating cell cultures: Immunocytochemical, electron microscopic and biochemical observations. J Neurosci 2: 986-993, 1982
30. Gundersen HJG, Jensen EB: The efficiency of systematic sampling in stereology and its prediction. J Microscopy 147: 229-263, 1987
31. Pedersen PH, Rucklidge G, Mork S, Terzis AJA, Engebraaten O, Lund-Johansen M, Backlund EO, Laerum OD, Bjerkvig R: Leptomeningeal tissue: a barrier against glioma cell invasion. J Natl Cancer Inst 86: 1593-1599, 1994
32. Pedersen PH, Marienhagen K, Mork S, Bjerkvig R: The migratory pattern of fetal rat brain cells and human glioma cells in the adult rat brain. Cancer Res 53: 5158-5165, 1993
33. Storme G, Mareel MM, De Bruyne G: Influence of cell number on directional migration of MO 4 cells in vitro. Arch Gesschwulstforsch 51: 45-50, 1981
34. Carlsson J, Nederman T: Tumor spheroids as a model in studies of drug effects. In: Bjerkvig R (ed) Spheroid Culture in Cancer Research. CRP Press, Boca Raton (FL), Ann Arbor, London, 1992, pp 199-216
35. Mamont PS, Duschesne MC, Joder-Ohlenbusch AM, Grove J: Effects of ornithine decarboxylase inhibitors on cultured cells. In: Seiler N, Jung MJ, Koch-Weser J (eds) Enzymeactivated Irreversible Inhibitors. Elsevier/North Holland Biomedical Press, Amsterdam, 1978, pp 43-54
36. Prehn RT: Many growth factors may not be growth factors. Cancer Res 52: 501-507, 1992
37. Lund-Johansen M, Bjerkvig R, Rucklidge GJ: Tumor spheroids from monolayer cultures. In: Bjerkvig R (ed) Spheroid Culture in Cancer Research. CRP Press, Boca Raton (FL), Ann Arbor, London, 1992, pp 199-216